Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3034 |
|
Actual shortage: | 241 (8%) | |
Anticipated shortage: | 18 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO AMPI CAPSULES 500MG | 500MG | CAPSULE | Actual shortage | 2017-08-16 | 2017-10-05 | 19589 |
APO AMPI CAPSULES 250MG | 250MG | CAPSULE | Actual shortage | 2017-08-16 | 2017-10-05 | 19582 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Resolved | 2017-03-12 | 2017-10-10 | 701 |
APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2017-12-05 | 2018-07-03 | 31812 |
APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2019-09-12 | 2019-10-18 | 93665 |
ANTI-NAUSEANT | 50MG | TABLET | Resolved | 2018-02-05 | 2018-09-12 | 38526 |
ANAFRANIL | 50MG | TABLET | Resolved | 2020-07-07 | 2020-09-03 | 119627 |
ANAFRANIL | 25MG | TABLET | Resolved | 2020-07-23 | 2020-09-03 | 121017 |
ANAFRANIL | 25MG | TABLET | Resolved | 2021-02-26 | 2021-03-15 | 134799 |
ANAFRANIL | 50MG | TABLET | Resolved | 2021-11-22 | 2021-12-20 | 149702 |
ANAFRANIL | 25MG | TABLET | Resolved | 2022-03-18 | 2022-04-04 | 156980 |
ANAFRANIL | 50MG | TABLET | Resolved | 2023-10-20 | 2023-12-22 | 207713 |
ANAFRANIL | 25MG | TABLET | Resolved | 2024-03-15 | 2024-03-22 | 222473 |
ALYSENA 28 | 20MCG 100MCG | TABLET | Resolved | 2018-02-26 | 2018-04-12 | 41130 |
ALYSENA 28 | 20MCG 100MCG | TABLET | Resolved | 2019-05-15 | 2019-09-16 | 84101 |
ALYSENA 28 | 20MCG 100MCG | TABLET | Resolved | 2020-03-18 | 2020-04-13 | 108920 |
ALYSENA 28 | 20MCG 100MCG | TABLET | Resolved | 2021-10-08 | 2021-12-13 | 146898 |
ALYSENA 21 | 20MCG 100MCG | TABLET | Resolved | 2018-02-27 | 2018-05-03 | 41160 |
ALYSENA 21 | 20MCG 100MCG | TABLET | Resolved | 2019-05-15 | 2019-08-08 | 84096 |
ALYSENA 21 | 20MCG 100MCG | TABLET | Resolved | 2019-11-20 | 2019-12-09 | 99287 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
APO-QUININE | 200MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60711 |
APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
APO-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60708 |
APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119950 |